Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cyril Planchais

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Blood|November 6, 2009
Induction of heme oxygenase-1 in factor VIII-deficient mice reduces the immune response to therapeutic factor VIIIJordan D Dimitrov, Suryasarathi Dasgupta, Ana-Maria Navarrete, et al.
Journal of Virology|September 19, 2022
The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 VariantsStacy Gellenoncourt, Nell Saunders, Rémy Robinot, et al.
Cell Reports|December 17, 2025
In vivo efficacy of combined human broadly neutralizing antibodies against hepatitis B virusMaxime Beretta, Ariel Mechaly, Cyril Planchais, et al.
Science Advances|May 7, 2025
Structural basis for hepatitis E virus neutralization by potent human antibodiesLuis M Molinos-Albert, Eduard Baquero, Cyril Planchais, et al.
Cell Reports|May 31, 2018
Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers PolyreactivityJulie Prigent, Annaëlle Jarossay, Cyril Planchais, et al.
The EMBO Journal|October 14, 2020
Syncytia formation by SARS-CoV-2-infected cellsJulian Buchrieser, Jérémy Dufloo, Mathieu Hubert, et al.
Frontiers in Immunology|July 5, 2021
CD32<sup>+</sup>CD4<sup>+</sup> T Cells Sharing B Cell Properties Increase With Simian Immunodeficiency Virus Replication in Lymphoid TissuesNicolas Huot, Philippe Rascle, Cyril Planchais, et al.
Cell Host & Microbe|September 7, 2024
Intestinal newborn regulatory B cell antibodies modulate microbiota communitiesQisheng Gu, Marion Draheim, Cyril Planchais, et al.
Pathogens & Immunity|October 11, 2024
Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP3.3 From Approved Monoclonal AntibodiesDelphine Planas, Isabelle Staropoli, Cyril Planchais, et al.
Nature Immunology|November 3, 2023
SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cellsNicolas Huot, Cyril Planchais, Pierre Rosenbaum, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Blood|November 6, 2009
Induction of heme oxygenase-1 in factor VIII-deficient mice reduces the immune response to therapeutic factor VIIIJordan D Dimitrov, Suryasarathi Dasgupta, Ana-Maria Navarrete, et al.
Journal of Virology|September 19, 2022
The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 VariantsStacy Gellenoncourt, Nell Saunders, Rémy Robinot, et al.
Cell Reports|December 17, 2025
In vivo efficacy of combined human broadly neutralizing antibodies against hepatitis B virusMaxime Beretta, Ariel Mechaly, Cyril Planchais, et al.
Science Advances|May 7, 2025
Structural basis for hepatitis E virus neutralization by potent human antibodiesLuis M Molinos-Albert, Eduard Baquero, Cyril Planchais, et al.
Cell Reports|May 31, 2018
Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers PolyreactivityJulie Prigent, Annaëlle Jarossay, Cyril Planchais, et al.
The EMBO Journal|October 14, 2020
Syncytia formation by SARS-CoV-2-infected cellsJulian Buchrieser, Jérémy Dufloo, Mathieu Hubert, et al.
Frontiers in Immunology|July 5, 2021
CD32<sup>+</sup>CD4<sup>+</sup> T Cells Sharing B Cell Properties Increase With Simian Immunodeficiency Virus Replication in Lymphoid TissuesNicolas Huot, Philippe Rascle, Cyril Planchais, et al.
Cell Host & Microbe|September 7, 2024
Intestinal newborn regulatory B cell antibodies modulate microbiota communitiesQisheng Gu, Marion Draheim, Cyril Planchais, et al.
Pathogens & Immunity|October 11, 2024
Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP3.3 From Approved Monoclonal AntibodiesDelphine Planas, Isabelle Staropoli, Cyril Planchais, et al.
Nature Immunology|November 3, 2023
SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cellsNicolas Huot, Cyril Planchais, Pierre Rosenbaum, et al.
Pageof 7